2023-06-01 2024-05-31 false Capium Accounts Production 1.1 09027381 2023-06-01 2024-05-31 09027381 bus:AbridgedAccounts 2023-06-01 2024-05-31 09027381 bus:FRS102 2023-06-01 2024-05-31 09027381 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 09027381 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 09027381 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 09027381 2023-06-01 2024-05-31 09027381 2024-05-31 09027381 bus:RegisteredOffice 2023-06-01 2024-05-31 09027381 core:WithinOneYear 2024-05-31 09027381 core:AfterOneYear 2024-05-31 09027381 1 2023-06-01 2024-05-31 09027381 bus:Director1 2023-06-01 2024-05-31 09027381 bus:Director1 2024-05-31 09027381 bus:Director1 2022-06-01 2023-03-31 09027381 2022-06-01 09027381 bus:LeadAgentIfApplicable 2023-06-01 2024-05-31 09027381 2022-06-01 2023-03-31 09027381 2023-03-31 09027381 core:WithinOneYear 2023-03-31 09027381 core:AfterOneYear 2023-03-31 09027381 bus:EntityAccountantsOrAuditors 2022-06-01 2023-03-31 09027381 core:MotorCars 2023-06-01 2024-05-31 09027381 core:MotorCars 2024-05-31 09027381 core:MotorCars 2023-03-31 09027381 core:FurnitureFittings 2023-06-01 2024-05-31 09027381 core:FurnitureFittings 2024-05-31 09027381 core:FurnitureFittings 2023-03-31 09027381 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-05-31 09027381 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-03-31 09027381 core:CostValuation core:Non-currentFinancialInstruments 2024-05-31 09027381 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 09027381 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-05-31 09027381 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-05-31 09027381 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-05-31 09027381 core:Non-currentFinancialInstruments 2024-05-31 09027381 core:Non-currentFinancialInstruments 2023-03-31 09027381 core:ShareCapital 2024-05-31 09027381 core:ShareCapital 2023-03-31 09027381 core:RetainedEarningsAccumulatedLosses 2024-05-31 09027381 core:RetainedEarningsAccumulatedLosses 2023-03-31 09027381 dpl:Item1 2023-06-01 09027381 dpl:Item1 2024-05-31 09027381 dpl:Item1 2022-06-01 09027381 dpl:Item1 2023-03-31 iso4217:GBP xbrli:shares xbrli:pure
Logo On Report
Registered Number: 09027381
England and Wales

 

 

 

GINKGOHEALTH LTD


Abridged Accounts
 


Period of accounts

Start date: 01 June 2023

End date: 31 May 2024
Accountant’s report
You consider that the company is exempt from an audit for the year ended 31 May 2024 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Debo Konsult
31 May 2024



....................................................

Debo Konsult

33 Lulworth Crescent
Mitcham
Croydon
CR4 3RB
27 February 2025
1
 

 
Notes

 
2024
£

  2023
£
(as restated)
Fixed assets      
Tangible fixed assets 4 374    746 
374    746 
Current assets      
Cash at bank and in hand 1,948    2,178 
Creditors: amount falling due within one year (107,801)   (99,558)
Net current assets (105,853)   (97,380)
 
Total assets less current liabilities (105,479)   (96,634)
Creditors: amount falling due after more than one year   (1,674)
Net assets (105,479)   (98,308)
 

Capital and reserves
     
Called up share capital 100    100 
Profit and loss account (105,579)   (98,408)
Shareholders' funds (105,479)   (98,308)
 


For the year ended 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the profit and loss account has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 27 February 2025 and were signed by:


-------------------------------
Lei Sun Lake
Director
2
General Information
Ginkgohealth Ltd is a private company, limited by shares, registered in England and Wales, registration number 09027381, registration address 9a rosslyn mews, Hamstead. Camden, London, Greater London, NW3 1NN.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Government grants
Government grants received are credited to deferred income. Grants towards capital expenditure are released to the profit and loss account over the expected useful life of the assets. Grants received towards revenue expenditure are released to the profit and loss account as the related expenditure is incurred.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Motor Vehicles 25 Straight Line
Fixtures and Fittings 20 Straight Line
2.

Directors' Emoluments

2024
£
  2023
£
Administrative Expenses
Directors Salaries 10,000    4,548 
10,000    4,548 

3.

Average number of employees

Average number of employees during the year was 2 (2023 : 2).
4.

Tangible fixed assets

Cost or valuation Motor Vehicles   Fixtures and Fittings   Total
  £   £   £
At 01 June 2023 8,265    3,275    11,540 
Additions    
Disposals    
At 31 May 2024 8,265    3,275    11,540 
Depreciation
At 01 June 2023 8,265    2,529    10,794 
Charge for year   372    372 
On disposals    
At 31 May 2024 8,265    2,901    11,166 
Net book values
Closing balance as at 31 May 2024   374    374 
Opening balance as at 01 June 2023   746    746 


3